Cargando…
Value-based healthcare: Il nuovo approccio di AIFA alla determinazione multidimensionale del valore
In this viewpoint, we discuss the approach promoted by the Italian Drug Agency (AIFA) to the assessment of the value of new pharmaceuticals in the Italian Healthcare Service. On top of traditionally acknowledged components, such as quality adjusted life years gained and net costs, the overall value...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AboutScience
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677615/ https://www.ncbi.nlm.nih.gov/pubmed/36627957 http://dx.doi.org/10.33393/grhta.2020.2102 |